Scroll to top

Extracellular Vesicle Research Exchanges for Advanced Biomarkers and Therapeutics We're focused on extracellular vesicles

01.

International collaboration

Pioneering research exchanges

EVEREST enables international staff mobility and collaboration across 21 institutions in 11 countries, advancing the field of extracellular vesicles (EVs) for diagnostics and therapeutics.

02.

Tackling global health challenges

Innovative solutions for global health

The consortium drives cutting-edge research to develop new biomarkers and therapies for diseases like cancer, cardiovascular, neurodegenerative, and autoimmune disorders, directly addressing major global health challenges.

03.

Advanced training & mobility

Interdisciplinary & intersectoral training

Through fully funded placements in top academic and industrial centres, researchers gain access to state-of-the-art technologies, advanced methodologies, and broad professional networks, enhancing their expertise and career prospects.

04.

From research to impact

From siscovery to real-world impact

EVEREST bridges research and application, translating scientific breakthroughs into clinical and industrial solutions, and supporting the commercialisation of EV-based innovations for societal benefit.

Consult the EVEREST Dossier to learn how to join our international research network.

Discover Participation Guidelines

Participate in fully funded secondments at top-tier institutions and innovative SMEs. Experience a dynamic, multicultural research environment, gain new skills, and broaden your professional network through interdisciplinary training and international mobility.

International Research Exchanges

0%

Advanced Skills Development

0%

Access to Cutting-Edge Infrastructure

0%

Career Networking & Mentoring

0%

Through EVEREST, participants benefit from high-quality secondments, access to interdisciplinary expertise, and comprehensive support throughout their mobility experience, ensuring a significant boost to their scientific careers.

EVEREST brings together leading scientists and companies to push the boundaries of extracellular vesicle research. Our focus: advanced biomarker discovery, innovative therapeutic strategies, and technology standardisation across Europe and beyond. Join us to collaborate on interdisciplinary projects tackling urgent health challenges such as cancer, cardiovascular and neurodegenerative diseases.

EVEREST accelerates the translation of scientific discoveries into clinical and industrial solutions. We foster strong academia-industry collaboration, supporting the development and commercialisation of EV-based diagnostics and therapies, with real benefits for patients and society.

Wide European Reach

Connected network

Collaborative network spanning 11 countries across Europe, connecting leading research institutions and innovative companies.

Academic & Industry Partnership

Joint innovation

Bridging academic excellence and technological leadership by joining top universities, research centres, and pioneering SMEs.

Multidisciplinary Expertise

Broad knowledge

Combining knowledge in oncology, cardiology, neuroscience, bioengineering, and biotechnology for a comprehensive approach to EV science.

Proven Excellence in EU Projects

Trusted leadership

Coordinated by institutions with a strong track record in managing successful EU research consortia and international collaborations.

0

STAFF MONTHS EXCHANGED

Total mobility

0

CONSORTIUM PARTNERS

Institutions involved

0

EUROPEAN COUNTRIES

International scope

0

PARTICIPATING FELLOWS

Career development

EVEREST

Extracellular Vesicle Research Exchanges for Advanced Biomarkers and Therapeutics. (Horizon Europe-SE2023/GA101183034)

Staff Exchanges. Marie Skłodowska-Curie actions.

Funding Acknowledgment:

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. (GA101183034)

Get in touch

Let's Talk

  • Address:

    Ocular Pharmacology and Genetics Group
    UCD SBBS, UCD Conway Institute
    Belfield campus
    University College Dublin
  • Email:

    yolanda.alvarez@ucd.ie
  • Email:

    brendan.kennedy@ucd.ie
  • +35317166740

Get in touch

Say Hello